Neurovance Obtains $314,601 New Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c42e79e8-4455-4ff7-8cc8-0a731a13bd5e&Preview=1 -
Date
5/31/2012 -
Company Name
Neurovance -
Mailing Address
43 Thorndike Street Cambridge, MA 02141 -
Company Description
Neurovance is a stealth pharmaceutical company developing pharmaceutical preparations for the treatment of disorder of the central nervous system. -
Website
Undisclosed
-
Transaction Type
Venture Equity -
Transaction Amount
$314,601 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
